Wall Street Week | Tariff Legality, Businesses on Mamdani, Pediatrics Under Pressure, Protein BoomNovember 8, 2025
Share Facebook Twitter LinkedIn Pinterest Email CNBC’s “Money Movers” team discusses Palantir’s second-quarter earnings report as the stock hits a record high after the company reported its first $1 billion revenue quarter with Michal Lev-Ram, CNBC contributor and contributing editor at Fortune.